Upregulation of MACC1 has been found in colorectal cancer (7, 12), gastric cancer (13–15), liver cancer (16, 17), lung cancer (18), non-small cell lung cancer (19), cervical cancer (20, 21), ovarian cancer (22), NPC (11, 23), and malignant gliomas (24). This evidence concerns the gene MACC1 and nasopharyngeal carcinoma.